- Home
- ULH vs VIR Comparison
ULH vs VIR Comparison
Compare ULH & VIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ULH
- VIR
- Stock Information
- Founded
- ULH 1932
- VIR 2016
- Country
- ULH United States
- VIR United States
- Employees
- ULH N/A
- VIR N/A
- Industry
- ULH Trucking Freight/Courier Services
- VIR Biotechnology: Pharmaceutical Preparations
- Sector
- ULH Industrials
- VIR Health Care
- Exchange
- ULH Nasdaq
- VIR Nasdaq
- Market Cap
- ULH 635.2M
- VIR 706.4M
- IPO Year
- ULH 2005
- VIR 2019
- Fundamental
- Price
- ULH $23.34
- VIR $5.10
- Analyst Decision
- ULH Hold
- VIR Strong Buy
- Analyst Count
- ULH 1
- VIR 8
- Target Price
- ULH $29.00
- VIR $30.25
- AVG Volume (30 Days)
- ULH 57.6K
- VIR 1.1M
- Earning Date
- ULH 07-24-2025
- VIR 08-06-2025
- Dividend Yield
- ULH 1.85%
- VIR N/A
- EPS Growth
- ULH N/A
- VIR N/A
- EPS
- ULH 2.31
- VIR N/A
- Revenue
- ULH $1,668,148,000.00
- VIR $20,861,000.00
- Revenue This Year
- ULH N/A
- VIR N/A
- Revenue Next Year
- ULH $7.88
- VIR $0.56
- P/E Ratio
- ULH $10.02
- VIR N/A
- Revenue Growth
- ULH N/A
- VIR N/A
- 52 Week Low
- ULH $20.60
- VIR $4.32
- 52 Week High
- ULH $53.29
- VIR $14.45
- Technical
- Relative Strength Index (RSI)
- ULH 38.21
- VIR 41.94
- Support Level
- ULH $24.92
- VIR $4.89
- Resistance Level
- ULH $30.76
- VIR $5.92
- Average True Range (ATR)
- ULH 1.67
- VIR 0.25
- MACD
- ULH -0.53
- VIR -0.07
- Stochastic Oscillator
- ULH 0.00
- VIR 19.63
About ULH Universal Logistics Holdings Inc.
Universal Logistics Holdings Inc is an asset-light provider of customized transportation and logistics solutions throughout the United States, and in Mexico, Canada and Colombia. It offers services such as truckload, brokerage, intermodal, dedicated, and value-added services. The company reports into four segments namely trucking, intermodal, company-managed brokerage, and contract logistics. The majority of the revenue is earned from the contract logistics segment.
About VIR Vir Biotechnology Inc.
Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.